Amneal to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Amneal (Nasdaq: AMRX) announced executives will participate in two investor conferences and that presentations will be webcast. Chirag Patel, Co‑Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will join the Piper Sandler 2025 Healthcare Conference for a fireside chat on December 3, 2025 at 9:30 AM EST in New York. They will also present at the J.P. Morgan 2026 Healthcare Conference on January 13, 2026 at 4:30 PM PST in San Francisco. A webcast and limited-time replays will be available on Amneal's Investor Relations site.

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will participate in following upcoming investor conferences:

Piper Sandler 2025 Healthcare Conference
Date: December 3, 2025
Fireside Chat: Wednesday, December 3, 2025, at 9:30AM EST
Location: New York, NY

J.P. Morgan 2026 Healthcare Conference
Date: January 12-15, 2026
Presentation: Tuesday, January 13, 2026, at 4:30PM PST
Location: San Francisco, CA

A webcast of the presentations will be available on Amneal’s Investor Relations website at www.amneal.com/investors. Replays will be available for a limited time following each event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 290 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.

Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com

FAQ

When is Amneal's fireside chat at the Piper Sandler 2025 Healthcare Conference (AMRX)?

The fireside chat is scheduled for December 3, 2025 at 9:30 AM EST in New York.

Who from Amneal (AMRX) will present at the Piper Sandler conference on December 3, 2025?

Chirag Patel, Co‑Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will participate.

When and where will Amneal present at the J.P. Morgan 2026 Healthcare Conference (AMRX)?

Amneal will present on January 13, 2026 at 4:30 PM PST in San Francisco, during the J.P. Morgan 2026 Healthcare Conference.

How can investors watch Amneal's (AMRX) conference presentations online?

A live webcast will be available on Amneal's Investor Relations website at www.amneal.com/investors.

Will replays of Amneal's (AMRX) presentations be available after the events?

Yes. Replays will be available for a limited time on the company's Investor Relations website following each event.

What executives will represent Amneal (AMRX) at investor conferences in December 2025 and January 2026?

Chirag Patel and Tasos Konidaris will represent Amneal at the December 3, 2025 and January 13, 2026 events.